Search Results - Moreno-Villa, María Rocío

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract P5-02-44: Efficacy analysis of CDK4/6 inhibitors in combination with endocrine therapy treatment in HR+/HER2- breast cancer according to PAM50 intrinsic subtype: primary results of SOLTI-1801_CDK-PREDICT study

    Abstract P5-02-44: Efficacy analysis of CDK4/6 inhibitors in combination with endocrine therapy treatment in HR+/HER2- breast cancer according to PAM50 intrinsic subtype: primary r... by Tolosa, Pablo, Pascual, Tomás, Hernando, Cristina, Servitja, Sonia, Fernández, Adela, Brasó-Maristany, Fara, Benitez, Javier, Lema, Laura, Ruano, Yolanda, Parrilla, Lucia, Roncero, Ana María, Sánchez-Bayona, Rodrigo, Alva, Manuel, Villacampa, Guillermo, Moreno-Villa, María Rocío, Canes, Jordi, Salvador, Fernando, Prat, Aleix, Ciruelos, Eva

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition

    Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition by Cruz-Bermúdez, Alberto, Laza-Briviesca, Raquel, Vicente-Blanco, Ramiro J., García-Grande, Aránzazu, Coronado, Maria José, Laine-Menéndez, Sara, Palacios-Zambrano, Sara, Moreno-Villa, M. Rocío, Ruiz-Valdepeñas, Asunción Martin, Lendinez, Cristina, Romero, Atocha, Franco, Fernando, Calvo, Virginia, Alfaro, Cristina, Acosta, Paloma Martin, Salas, Clara, Garcia, José Miguel, Provencio, Mariano

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: